Johnson & Johnson and Merck are laying off workers in China, according to a story from Bloomberg which cites reports from ...

Triple-negative breast cancer, or TNBC, is a rare and especially aggressive form of breast cancer that grows and spreads ...

With Spanish plasma specialist Grifols turning down a potential multi-billion-dollar takeover bid, it’s likely back to the ...

It was only last October that UCB’s up-and-coming immunology powerhouse Bimzelx first crossed the FDA finish line in ...

Roche's spinal muscular atrophy (SMA) medicine Evrysdi only gained its FDA approval in 2020, but generics companies are ...

PCI Pharma Services, a CDMO, and the biotech ChiRhoClin inked a collaboration deal to address the potential shortage of a ...

Unexo Life Sciences, an Indian drugmaker that manufactures a medicated patch for pain relief, has been hit with a ...

As a council of outside experts prepares to meet Thursday to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety ...

As BeiGene works to change its corporate identity and grow the reach of its cancer offerings around the globe, the company ...

On Tuesday, company revealed that its subcutaneous formulation of Keytruda has aced a phase 3 trial, demonstrating ...

Robert F. Kennedy Jr.'s nomination as the Trump administration's Department of Health and Human Services (HHS) secretary has ...

With several high-profile manufacturing outlays already in the books in Europe this year, Sanofi is returning to the bloc in ...